Innovex International, Inc.
INVX · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.05 | 3.68 | -0.31 | -0.08 |
| FCF Yield | 2.86% | 4.82% | 1.93% | 4.13% |
| EV / EBITDA | 16.15 | 29.31 | 31.52 | 16.81 |
| Quality | ||||
| ROIC | 3.75% | 1.72% | 1.39% | 2.96% |
| Gross Margin | 31.64% | 25.31% | 31.82% | 33.85% |
| Cash Conversion Ratio | 1.23 | 3.86 | 2.11 | 1.14 |
| Growth | ||||
| Revenue 3-Year CAGR | 28.76% | 29.79% | 24.47% | 18.89% |
| Free Cash Flow Growth | -29.65% | 116.00% | -16.31% | 43.22% |
| Safety | ||||
| Net Debt / EBITDA | -1.09 | 0.79 | 0.37 | 0.42 |
| Interest Coverage | 92.00 | 50.65 | 31.21 | 71.77 |
| Efficiency | ||||
| Inventory Turnover | 0.60 | 0.60 | 0.61 | 0.61 |
| Cash Conversion Cycle | 197.07 | 217.63 | 206.63 | 207.42 |